Corvia Medical develops transcatheter device designed to reduce the symptoms or slow the progression of heart failure.
Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009 and headquartered in Andover, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 1, 2014 | Series D | $34M | 1 | — | — | Detail |
Mar 1, 2013 | Series C | $10.73M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
General Catalyst | — | Series D |